Glenmark Pharma’s US subsidiary has agreed to pay $15.28 million to settle antitrust litigation with Humana over allegations involving generic drug pricing and market allocation.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.